Roche-HIV.com
 
  Home | Disclaimer | Sitemap | Glossary | Library cart | Useful links | Keep me informed | Roche worldwide | Contact webmaster  
  
   Search this site
  Roche in HIV
  Understanding HIV
 
  About HIV
 
  HIV epidemiology
  HIV infection
  HIV disease and management
  Viral load
 
  Management issues
 
  Guidelines (HIV and HCV)
  Pharmaceutical products  
  Commitment to research  
  Commitment to access  
  Conferences  
  News and features
  Healthcare professionals

Before starting treatment, HIV-1 viral load measurements, along with CD4 counts, will guide both patient and doctor in deciding when to start treatment. If viral load levels remain consistently low, the decision to start taking HIV-1 medication may be delayed. With increasing or high viral load levels, a doctor may advise their patient to start highly active antiretroviral therapy.

Once an individual begins taking antiviral medication, their doctor will monitor the success of treatment by measuring the effects on HIV-1 viral load. An effective treatment should reduce viral load as much as possible (i.e. below 50 copies/ml). If viral load does not decrease so that it becomes undetectable during treatment, a physician may recommend changing to a different treatment. Monitoring HIV-1 viral load is extremely important as it provides the physician with the information required to determine whether a change in drug therapy is needed. The sensitivity of the AMPLICOR HIV-1 MONITORTest allows a doctor to tailor their patient�s therapy and to respond quickly to changes in viral load status.

« Previous Viral load Menu Next »
Home | Disclaimer | Sitemap | Glossary | Library cart | Useful links | Keep me informed | Roche worldwide
All information contained in this website is generated and maintained by F. Hoffmann-La Roche, Ltd, Basel, Switzerland. This site is intended for use by physicians only. This site is not intended for residents of the United States of America.
Copyright 2006 F. Hoffmann La Roche Ltd.
Contact webmaster